Abstract
Integrins and discoidin domain receptors (DDRs) 1 and 2 promote cell adhesion and migration on both fibrillar and non fibrillar collagens. Collagen I contains DDR and integrin selective binding motifs; however, the relative contribution of these two receptors in regulating cell migration is unclear. DDR1 has five isoforms (DDR1a-e), with most cells expressing the DDR1a and DDR1b isoforms. We show that human embryonic kidney 293 cells expressing DDR1b migrate more than DDR1a expressing cells on DDR selective substrata as well as on collagen I in vitro. In addition, DDR1b expressing cells show increased lung colonization after tail vein injection in nude mice. DDR1a and DDR1b differ from each other by an extra 37 amino acids in the DDR1b cytoplasmic domain. Interestingly, these 37 amino acids contain an NPxY motif which is a central control module within the cytoplasmic domain of β integrins and acts by binding scaffold proteins, including talin. Using purified recombinant DDR1 cytoplasmic tail proteins, we show that DDR1b directly binds talin with higher affinity than DDR1a. In cells, DDR1b, but not DDR1a, colocalizes with talin and integrin β1 to focal adhesions and enhances integrin β1-mediated cell migration. Moreover, we show that DDR1b promotes cell migration by enhancing Rac1 activation. Mechanistically DDR1b interacts with the GTPase-activating protein (GAP) Breakpoint cluster region protein (BCR) thus reducing its GAP activity and enhancing Rac activation. Our study identifies DDR1b as a major driver of cell migration and talin and BCR as key players in the interplay between integrins and DDR1b in regulating cell migration.
Introduction
Cell adhesion and migration on fibrillar and non fibrillar collagens are mediated by several cell adhesion receptors such as integrins (Kechagia et al., 2019; ) and discoidin domain receptors (DDRs) ().
DDRs are receptor tyrosine kinases that consist of two closely related members DDR1 and DDR2. Upon collagen binding, DDRs undergo autophosphorylation on multiple tyrosine residues and initiate various downstream signaling pathways that regulate multiple cellular functions including cell adhesion and migration (). DDR1 has emerged as an important contributor and a therapeutic target in cancer growth and metastasis (Rikova et al., 2007; Lee et al., 2019; ; Sun et al., 2021). To this end, DDR1 is upregulated in cancer cells and it is directly involved in matrix remodeling, tumor cell migration, invasion and metastasis (Lee et al., 2018; ; Lin et al., 2020; Romayor et al., 2021). However, the mechanism whereby DDRs mediate cell adhesion and migration and whether they promote these cell functions in an integrin-dependent and/or -independent manner is poorly understood.
Even though DDRs and integrins have non overlapping and selective collagen binding sites (; Leitinger, 2003; Xu et al., 2011), DDRs and integrins can crosstalk with each other, thus influencing collagen-mediated cell adhesion and migration. To this end, DDR1 enhances the activation state of collagen-binding integrins α1β1 and α2β1, which strengthens their adhesion to collagen (Xu et al., 2012). Moreover, integrin α2β1 and DDR1 cooperate in regulating pancreatic cancer cells scattering (Shintani et al., 2008). In contrast to these findings, DDR1 seems to prevent collagen-induced epithelial cell migration, spreading and tubulogenesis by inhibiting integrin α2β1-mediated Cdc42 activation and STAT3 phosphorylation (Wang et al., 2006; Yeh et al., 2009). In support of a role for DDR1 in promoting cell migration, DDR1 overexpression in fibroblasts increases migration due to an interaction between DDR1 with the non-muscle myosin IIA (NMHC-IIA) (Xu et al., 2011). Interaction with NMIIA also promotes collagen fibers realignment by enhancing tractional remodeling forces (). Moreover, DDR1 has been shown to promote collective cancer cell invasion by coordinating the Par3/Par6 cell-polarity complex (); however, whether this is via an integrin dependent or independent mechanism is unclear.
DDR1 has five isoforms (DDR1a-e), with most cells expressing the DDR1a and DDR1b isoforms (). However, the relative contribution of DDR1a and DDR1b to cell adhesion, migration, and invasion is unclear. To this end, overexpression of DDR1a, but not DDR1b, stimulates cell migration and invasion of glioma cells (Ram et al., 2006). However, in non-small cell lung carcinomas both isoforms promote cell migration upon collagen stimulation (Yang et al., 2010), while overexpression of DDR1b inhibits lung colonization of HT1080-derived tumors (Wasinski et al., 2020).
Although the mechanism underlying the functional differences between DDR1a and DDR1b is unknown, structural differences between isoforms have been suggested. Both isoforms encode functional receptor tyrosine kinases and the only difference between DDR1a and DDR1b is an extra 37 amino acids with an NPxY motif in the DDR1b intracellular juxtamembrane region preceding the kinase domain (). Interestingly, the integrin β cytoplasmic tail contains NPxY motifs essential for recruitment of focal adhesion proteins such as talin and kindlins (; Moser et al., 2009). This interaction increases integrin affinity for extracellular matrix components, thus facilitating interactions with the actin cytoskeleton and favoring cell adhesion, spreading and migration (Rognoni et al., 2016; Theodosiou et al., 2016; Sun et al., 2019).
In this study, we provide evidence that DDR1b is more effective than DDR1a in mediating integrin-dependent and -independent cell adhesion and migration. Mechanistically, DDR1b binds talin and it colocalizes with talin and integrin β1 to focal adhesions. Moreover, we show that DDR1b stimulates cell migration on collagen I by promoting the activation of the small GTPase Rac1, thus revealing a novel DDR1b-Rac1 axis.
Results
Increased Lung Colonization of DDR1b-Expressing Cells
The collagen binding receptor DDR1 has been shown to contribute to cell migration (). However, the relative contribution of the two major DDR1 isoforms 1a and 1b in mediating this cell function is unclear. Since human embryonic kidney (HEK) cells are tumorigenic in vivo (Scherpereel et al., 2003; Macias-Perez et al., 2008), we generated stable cell lines of HEK cells expressing comparable levels of human DDR1a and DDR1b (Figure 1A) and GFP. Compared to HEK cells transfected with vector alone which express low/undetectable levels of endogenous DDR1 (Figure 1B), robust DDR1a and DDR1b expression was detected by western blot in DDR1a- and DDR1b-expressing HEK cells (Figure 1B). Moreover, both DDR1a and DDR1b were phosphorylated upon treatment of cells with soluble collagen I (Figure 1B) indicating that these two receptors bind to and are activated by collagen I. We intravenously injected athymic mice with GFP-expressing HEK-Vector, HEK-DDR1a or HEK-DDR1b cells. Two weeks later, we harvested the lungs and counted the number of GFP positive colonies within the lung parenchyma. The number of colonies generated by HEK-DDR1b cells was significantly higher than those generated by HEK-Vector or HEK-DDR1a cells (Figures 1C,D), suggesting that DDR1b promotes robust cell invasion in vivo.
FIGURE 1
DDR1b Promotes Adhesion and Migration on DDR Selective Substrata
Fibrillar collagens contain specific binding sites for DDR1 (GVMGFO) and integrins α1β1 and α2β1 (GLOGEN, GFOGER) (Leitinger, 2011). To analyze the relative contribution of DDR1 in cell adhesion and migration, we generated DC1-GVMGFP, a bacterial collagen-like polypeptide containing the collagen-binding site of DDR1 in a triple helical molecule (Supplementary Figures S1A–D). These bacterial collagen-like proteins specifically bind to DDR1 and inhibit DDR1-collagen interactions (). To determine whether DC1-GVMGFP activates DDR1 we treated DDR1b expressing HEK cells with different amounts of DC1-GVMGFP or DC1 (lacking the DDR1 binding site) and collagen I (CI, positive control) and then measured DDR1 phosphorylation. DC1-GVMGFP, but not DC1, induced a 3.6 ± 0.6 fold increase in DDR1 phosphorylation (three independent experiments) (Supplementary Figure S1E). We also found that in HEK-DDR1a cells, DC1-GVMGFP induced DDR1 phosphorylation, although it was to a lower extent than that detected in HEK-DDR1b cells (pDDR1/DDR1, 1.8 ± 0.6 for DDR1a vs 3.6 ± 0.6 for DDR1b) (Figure 2A).
FIGURE 2
Next, we analyzed the relative contribution of DDR1a and DDR1b to adhesion and migration on DC1 and DC1-GVMGFP. HEK-Vector, HEK-DDR1a, and HEK-DDR1b cells adhered significantly more on DC1-GVMGFP when compared to DC1 (Figure 2B). However, HEK-DDR1b cells adhered to DC1-GVMGFP significantly more than HEK-Vector and HEK-DDR1a (Figure 2B). There were no significant differences in cell adhesion between HEK-Vector and HEK-DDR1a on DC1-GVMGFP (Figure 2B) raising the possibility that endogenous DDRs in HEK cells may contribute to the adhesion on this substrate. Next, we measured cell migration and found that compared to DC1, DC1-GVMGFP promoted a significant migration only in cells expressing DDR1b, but not vector or DDR1a (Figure 2C). On DC1-GVMGFP, HEK-DDR1b cells migrated significantly more compared to HEK-Vector or HEK-DDR1a (Figure 2C). These results suggest that adhesion on and migration towards DC1-GVMGFP are integrin-independent and mediated prevalently by DDR1b.
Since collagen I is the major ligand for DDR1 (Shrivastava et al., 1997; Vogel et al., 1997), we examined whether DDR1a and DDR1b differentially support adhesion and migration on this substrate. Compared to HEK-Vector cells, both HEK-DDR1b and HEK-DDR1a cells adhered more on collagen I, but the increase in adhesion was significant only for HEK-DDR1b cells (Figure 3A). There were no significant differences in adhesion to collagen I between HEK-DDR1a and HEK-DDR1b cells (Figure 3A). In contrast, HEK-DDR1b migrated towards collagen I significantly more than HEK-DDR1a or HEK-Vector cells (Figure 3B).
FIGURE 3
In cells plated on collagen I, DDR1b, but not DDR1a, co-localized with activated integrin β1, as determined by staining with an antibody thar recognizes the active conformation of integrin β1 (12G10) (Mould et al., 1995) (Figures 3C,D) as well as F-actin and paxillin (Figures 3C,E,F). In contrast, when cells were plated on fibronectin, we failed to detect DDR1a or DDR1b colocalization to paxillin (Supplementary Figure S2). This result indicates that DDR1b is recruited to focal adhesions (FAs), integrin-containing multi-protein structures that connect the ECM to the actomyosin cytoskeleton and transmit traction forces required for cell migration, only in the presence of collagen (
To determine whether the effect of DDR1b on cell migration on collagen involves integrins, we depleted integrin β1 by siRNA in Vector-, DDR1a- and DDR1b-expressing HEK cells (Supplementary Figure S3B). In the control siRNA group, as expected, DDR1b significantly increased cell migration compared to Vector- or DDR1a-expressing cells (Figure 3G). Interestingly, depletion of integrin β1 equally abolished cell migration on collagen I in Vector-, DDR1a- and DDR1b-expressing cells (Figure 3G) suggesting that the effect of DDR1b on cell migration required integrin expression. Overall, on DC1-GVMGFP DDR1b mediates cell adhesion and migration in an integrin-independent manner. On collagen I, DDR1b co-localizes with activated integrin β1 to FAs and enhances integrin β1-mediated cell migration.
DDR1b Interacts With Talin
Talin is a major component of FAs and interacts with integrin β subunits (
Based on a structure of the talin F3 domain bound to the β3 integrin tail (PDB ID: 2h7e (Wegener et al., 2007)), we constructed 600,000 tentative structures of the DDR1b juxtamembrane region docked to talin F3 domain using the Rosetta protein modeling suite (see Methods) and found that the folding/docking trajectories converged on a well-defined, low-energy cluster of models, whose lowest energy representative is illustrated in Figure 4A. According to the Rosetta energy function, residues depicted as a “stick” (Figure 4A) contribute the most to the interaction energy. In this model the DDR1b-Y513 favorably interacts with talin-Y377 and forms a hydrogen bond with talin-L325. Furthermore, Y513 also undergoes a polar contact with DDR1-Y520, which in turn makes a hydrogen bond with L325. The NPxY motif of DDR1b consisting of N510-P511-(A512)-Y513 is instrumental in maintaining the interaction with talin by forming a network of hydrogen bonds to Y377 and immediately precedes talin-G376. The W359-A360-A361 residues of talin form an antiparallel beta sheet by means of a hydrogen bond network with the A531-W532-A533 residues of DDR1, which probably maintains the same conformation present in 2h7e integrin-talin structure. Notably, in this model, talin-Q381 lacks a strong interaction with DDR1b. If confirmed, this finding is in stark contrast to the published integrin structure [PDB ID: 2h7e (Wegener et al., 2007)]. We also observed that the conformation of the C-terminal part of DDR1b linker resembles the structure of the integrin template, while the N-terminal part is clearly different. In silico mutagenesis analysis performed to determine the influence of amino acid substitution on computed DDR1b (A505-Q541)-talin F3 domain binding energy, confirmed a key role of DDR1b-Y513 in maintaining the interaction with talin and Q349, G376 and Y377 of talin in maintaining the interaction with DDR1b (Supplementary Figure S5). Overall, these results suggest that DDR1b will bind with higher affinity to the talin head domain (THD) than DDR1a with the NPxY motif in DDR1b being critical for the interaction.
FIGURE 4

Talin binds better to DDR1b than DDR1a. (A) Model of binding between DDR1b intracellular domain (A505-Q541) and talin F3 domain. Talin F3 domain is in pink, DDR1b A505-Q541 is in light blue and the NPxY motif of DDR1b is highlighted in dark blue. Side chains of the amino acids discussed in text have been shown in sticks. (B) TurboID, DDR1a-turbo or DDR1b-turbo HEK expressing cells were plated on collagen I (30 μg/ml) for 1–3 h and then lysed and subjected to Streptavidin (SA) pull-down (PD) followed by western blotting with talin or DDR1 antibodies. (C) Immobilized talin head domain (3 µg/ml) was incubated with increasing amounts of purified cytoplasmic domains of DDR1a or DDR1b and the bound DDR1 was detected with anti-DDR1 antibody. Raw data in C were fitted with Non Linear Regression–Global Curve Fitting with one site saturation using Sigma Plot and the calculated Kd were compared using a two-tailed t-test. (D) HEK cells were stable transfected with either empty vector, DDR1b or HEK-DDR1b-Y513A cDNAs and cell populations expressing comparable levels of DDR1 were sorted by FACS. (E) Total internal reflection fluorescence (TIRF) microscopy of HEK-DDR1a, HEK-DDR1b and DDR1b-Y513A cells stable transfected with full length talin1-GFP plated on collagen I (20 µg/ml) for 1 h and then stained with anti-DDR1 or 12G10 antibody. Overlay images reveal co-localization of 12G10 and talin (positive control) and DDR1b with talin. (F) Co-localization of DDR1a, DDR1b and DDR1b-Y513A with talin1-GFP at the cell membrane of cells plated on collagen I was determined using the ImageJ/JACoP analysis and the Manders’ overlap coefficient (
To determine whether DDR1 co-localizes with talin in live cells, first we used a proximity-dependent labeling method, BioID. In BioID one of the proteins, the bait, is fused to a biotin ligase, turbo-Flag, which will biotinylate proteins in close proximity (∼10 nm) (Varnaite and MacNeill, 2016) to the bait. This method allows biochemical identification of transient, low affinity interactors in live cells. We generated HEK cells expressing DDR1a-turbo, DDR1b-turbo or the biotin ligase alone and plated cells on collagen I. Next, we isolated the biotinylated proteins and performed Western blot analysis with an anti-talin antibody. We found that in DDR1b-turbo cells there was a 2.29 ± 0.79 fold increase (three independent experiments) in the levels of biotinylated talin than in cells expressing DDR1a-turbo (Figure 4B), suggesting that DDR1b is in closer proximity with talin than DDR1a.
To determine whether DDR1 interacts directly with talin and to confirm the model that DDR1b binds talin with higher affinity than DDR1a, we used binding assays with purified recombinant proteins. For the binding assay, we incubated baculovirus expressed DDR1a and DDR1b cytoplasmic domains (Supplementary Figure S4A, Figure 4B) with bacterially expressed talin head domain (THD, a. a. 1–433) (Supplementary Figure S4C). For detection of bound DDR1 we used an antibody recognizing a common epitope at the C-terminus of DDR1 (Supplementary Figure S4D). We found that DDR1b bound with a significantly higher affinity than DDR1a to immobilized THD (Figure 4C).
Finally, to support the interaction of talin and DDR1b in HEK cells and to evaluate the role of NPxY motif in the interaction with talin, we expressed GFP-talin in HEK-DDR1a and HEK-DDR1b cells as well as in cells expressing a Y-to-A mutation within the NPxY motif of DDR1b (HEK-DDR1b-Y513A) (Figure 4D). Next, we examined talin co-localization with DDR1 on cells plated on collagen I. DDR1b, but not DDR1a or DDR1b-Y513A, co-localized with talin (Figures 4E,F) to FAs, thus confirming that DDR1b interacts and co-localizes with talin more than DDR1a and that the NPxY motif is critical for co-localization with talin.
DDR1b Promotes Migration by Increasing Rac Activation
Depletion of integrin β1 abolishes DDR1b increased migration on collagen I (Figure 3F) which suggests that DDR1b enhances integrin β1-mediated cell migration. Because the closely related DDR2 was shown to activate integrins via Rap 1 mediated talin recruitment (
Breakpoint cluster region protein (BCR) is an interactor and downstream target of DDR1 (
FIGURE 5

DDR1b increases cell migration by inhibiting BCR GAP activity. (A) Turbo, DDR1a-turbo or DDR1b-turbo HEK expressing cells plated on collagen I (30 μg/ml) for 1–3 h were lysed and subjected to streptavidin (SA) pulldown (PD) followed by Western blot (IB) with anti-BCR or anti-DDR1 antibodies. (B) DDR1a or DDR1b expressing cells left in suspension or plated on collagen I (30 μg/ml) for 30 min, were lysed and analyzed for the levels of active Rac. The levels of Rac-GTP were adjusted to total Rac determined by western blot analysis. Values represent fold increase relative to cells left in suspension with the lowest levels of active Rac assigned a value of 1. Values are mean ± SEM of 3 independent experiments. Statistical analysis: one-way ANOVA followed by Tukey’s multiple comparison test. (C) Western blot analysis of cells transfected with Cnt siRNA or BCR siRNA. One representative experiment of 3 independent experiments is shown. (D) Migration of DDR1b cells transfected with Cnt siRNA or BCR siRNA toward collagen I (20 μg/ml). Values are the mean ± SEM of 3 independent experiments with 7 fields/microscopic field counted. (E) Western blot analysis of cells transfected with BCR or empty vector. One representative experiment of 3 independent experiments is shown. (F) Migration of DDR1b cell transfected with BCR or empty vector towards collagen I (20 μg/ml). Values are the mean ± SEM of 3 independent experiments with 7 fields/microscopic field counted. Statistical analysis for (D,F): unpaired two-tail t-test.(G) DDR1b cells transfected with BCR or empty vector were left in suspension or plated on collagen I for 30 min, lysed and then analyzed for the levels of active Rac using a G-LISA assay as described above. Values represent fold increase relative to cells transfected with empty vector with the lowest levels of active Rac left in suspension assigned a value of 1. Values are mean ± SEM of 3 independent experiments. Statistical analysis: one-way ANOVA followed by Tukey’s multiple comparison test.
Finally, to better define the role of the DDR1/BCR axis in regulating cell migration, we depleted or overexpressed BCR in DDR1b-expressing cells (as these cells have higher levels of Rac1-GTP, Figure 5B) and analyzed their migration on collagen I. We found that BCR depletion increased cell migration (Figures 5C,D) while BCR overexpression decreased cell migration (Figures 5E,F). Importantly, BCR overexpression significantly reduced Rac1 activation in DDR1b-expressing cells plated on collagen I (Figure 5G), suggesting that DDR1b potentiates Rac-1 activation by preventing BCR-mediated GAP activity.
Discussion
The goal of this study was to determine the relative contribution of DDR1a and DDR1b in mediating cell adhesion and migration. We provide evidence that DDR1b regulates cell adhesion, migration and invasion in an integrin-dependent and -independent manner. We show that DDR1b directly interacts with the cytoskeleton adaptor protein talin and co-localizes with talin and integrins to focal adhesions. Moreover, we show that DDR1b negatively regulates BCR GAP activity thus promoting Rac activation and in turn migration Figure 6.
FIGURE 6

Schematic representation of collagen I-mediated DDR1a vs DDR1b function. In cells expressing DDR1a and exposed to collagen I, this receptor does not co-localize with activated integrins in focal adhesions. In contrast, in cells expressing DDR1b and exposed to collagen I, this receptor binds more efficiently to talin, co-localizes with activated integrins in focal adhesions, and enhances integrin β1-mediated cell migration. In addition, DDR1b binds the GAP BCR thus enhancing Rac1 activation and migration.
Our results showing that bacterial collagen containing a selective DDR1 binding site promotes DDR1 phosphorylation differ from those reported by
Our results indicate that on the DDR1 selective substrate GVMGFP, DDR1b, but not DDR1a, promotes cell adhesion and migration. This finding is consistent with previous results indicating that DDRs can mediate integrin-independent cell adhesion (Xu et al., 2012). The extracellular domains of DDR1a and DDR1b are identical, and we generated HEK cells expressing comparable cell surface levels of these two isoforms. Thus, the differences in cell adhesion and migration exerted by DDR1b vs DDR1a are likely due to selective DDR1b-mediated recruitment of proteins controlling cell adhesion and migration, rather than differential binding to GVMGFP between the two isoforms. Moreover, we show that on collagen I, DDR1b but not DDR1a, promotes cell migration. This finding seems to disagree with previous studies showing that glioblastoma cells expressing DDR1a migrate and invade more compared to cells expressing DDR1b (Ram et al., 2006; Yang et al., 2010). This discrepancy may be attributed to cell type dependent effects or to the fact that expression of these two isoforms might alter the surface expression of integrins in tumor cells. To this end, in contrast to our study where all the cells we used express similar levels of integrin β1, integrin levels in DDR1 expressing glioblastoma cells were not investigated.
Simultaneous engagement of DDR1 and integrins via combinations of integrin- and DDR1-selective peptides was shown to synergistically increase cell adhesion compared to cells plated on integrin- or DDR1-specific peptides alone (Xu et al., 2012). Collagens contain both DDR1 and integrin binding sites and we found that depletion of integrin β1 in DDR1b-expressing cells reduces migration on collagen I to levels observed in vector-expressing cells. This result suggests that on collagen substrata DDR1b potentiates integrin-mediated cell migration rather than promoting migration in an integrin-independent manner. Several mechanisms have been proposed for DDR-mediated integrin activation. In cancer associated fibroblasts, DDR2 was shown to activate Rap1 which increases talin recruitment to integrin complexes and in turn increases integrin β1 activation (
In this study we show that DDR1 interacts and co-localizes with talin to FAs. Talin is essential for integrin activation, for linking the cytoplasmic tail of the integrins to the actin cytoskeleton and for stabilizing FAs. Talin consists of two major domains, the head and the rod domains. The N-terminal THD is a FERM domain consisting of F0, F1, F2, F3 subdomains. The F3 subdomain contains a phosphotyrosine-binding domain shown to bind the NPxY motif in the integrin β tails. In addition, this domain binds the hyaluronan receptor layilin, the phosphatidylinositol 4-phosphate 5-kinase type Iγ, focal adhesion kinase and the guanine nucleotide exchange factor TIAM1 (
Here, we show that DDR1b isoform promotes Rac1 activation by modulating BCR GAP activity. To this end, DDR1b-expresing cells have higher levels of Rac1-GTP than DDR1a-expressing cells; and BCR overexpression decreases Rac1 activation and in turn cell migration. This result is consistent with the finding that BCR inhibits macrophage directed migration by functioning as a GAP for Rac1 (
Interestingly, DDR1 seems to both activate and inhibit Rho GTPases in a cell type-dependent manner. In breast cancer cells, DDR1 increases Cdc42 activation and its specific guanine nucleotide-exchange factor (GEF) Tuba. This process is critical for linear invadosome formation (Juin et al., 2014). In contrast, in Madi-Darby canine kidney cells, both DDR1a and DDR1b isoform decrease Cdc42 activation and inhibit integrin-mediated cell spreading (Yeh et al., 2009). Our results clearly indicate that, in HEK293 cells, DDR1 promotes Rac1 activation and migration and that BCR is critical for this function.
How DDR1b regulates BCR GAP activity is not clear. DDR1-mediated phosphorylation of BCR inhibits BCR-β-catenin interaction thus removing the BCR inhibitory effect on β-catenin transcriptional activity (
DDR1 influences cell migration through multiple mechanisms (
In conclusion, our study identifies DDR1b as a major driver of cell adhesion, migration, and invasion in an integrin-dependent and -independent manner. DDR1b promotes migration by interacting and colocalizing with talin and integrins to FAs and by promoting Rac activation through inhibition of BCR GAP activity.
Materials and Methods
Plasmids
To generate full length pIRES-DDR1a the cDNA was released from pRK5-DDR1a with EcoRI and BamHI and cloned between the same site in pIRES-puro. The generation of pIRES-DDR1b and DDR1b-Turbo containing a Flag tag was previously described (
Antibodies
The following antibodies were used: DDR1 (Santa Cruz SC-532, 1:4,000 for WB and 1:2000 for ELISA; Cell Signaling #5583, clone D1G6, 1:2000 for WB and 1:1,000 for IF; mAb 7A9 (
Cells
Human embryonic kidney (HEK) 293 cells were maintained in DMEM supplemented with penicillin/streptomycin and 10% fetal bovine serum (FBS). Sf9 cells were grown at 27°C without CO2 in Grace Insect Medium supplemented with gentamicin and 10% FBS as monolayer. For protein expression Sf9 cells were grown in suspension in Sf-900 III serum-free medium (Life Technologies). HEK-DDR1b, HEK-Vector and HEK-DDR1b-Turbo were previously described (
Flow Cytometry
To sort cells for equal DDR1 surface expression or GFP expression, cells were collected with trypsin and recovered in 10% FBS media. 2–3x106 cells were incubated with antibodies to the extracellular domain of DDR1 (mAb 7A9 or AF2396) at 4°C for 1 h followed by incubation with either PE-conjugated anti mouse or Alexa-647-conjugated anti-goat secondary antibodies and sorted for equal DDR1 or DDR1 and GFP expression using a FACSAriall sorter from BD Biosciences, in the Research Flow Cytometry Core Laboratory at the Nashville VA Medical Center. Integrin β1 levels cells were determined by flow cytometry analysis as described (
Cell Adhesion and Migration Assay
Cell adhesion and migration were performed as previously described (
For cell adhesion, collagen I, DC1 and DC1-GVMGFP (3–30 µg/ml) were added to 96 well plates (Thermo Scientific) in 20 mM acetic acid or phosphate buffer saline (PBS), overnight at 4°C. Nonspecific binding sites were blocked as indicated above. 5 × 104 cells in 100 μl were added to each well and incubated at 37°C for 45 min for collagen I, or 33°C for 1 h for DC1 and DC1-GVMGFP. Non-adherent cells were removed by washing with PBS with Ca2+and Mg2+ and the attached cells were fixed with 4% paraformaldehyde, stained with 0.1% crystal violet (Sigma, 548-62-9) and lysed with 10% acetic acid and cell adhesion was quantified by reading the plates at 595 nm with a microtiter plate reader.
Depletion of Integrin β1 and BCR by siRNA
Silencer Select Validated small interfering RNAs (siRNA) for integrin β1 sense 5′-GCAGUUGGUUUUGCGAUUAtt and Silencer Select siRNA for BCR sense 5′-CAGAAGAAGUGUUUCAGAAtt were obtained from Life Technologies. For depletion experiments, HEK-Vector, HEK-DDR1a or HEK-DDR1b were plated in 6 well plates at 3 × 105 cells/well and transfected with 50 nM of each siRNA using Lipofectamine 2000 following the manufacturer protocol. After 24 h, the cells were re-transfected with the siRNA and after additional 48 h, they were collected and used for cell migration or Rac activation assays. FACS was used to ensure integrin β1 depletion while Western blot analysis was used to ensure downregulation of BCR.
Western Blots
Proteins from the various cells were extracted using Cell Signaling Cell Lysis Buffer (#9803) following manufacturer instructions and protein concentration was determined using a BCA assay (Thermo Scientific). Equal amounts of total proteins were separated onto SDS-PAGE and subsequently transferred to nitrocellulose membranes. Membranes were blocked with either 5% BSA for detection of phosphorylated proteins or 5% milk and then incubated with various primary antibodies followed by the appropriate HRP or IRdye-conjugated secondary antibodies. Immunoreactive bands were identified using enhanced chemiluminescence (Perkin-Elmer, NEL 104001) according to the manufacturer’s instructions or the Odyssey CLx imaging system. Bands were quantified either by densitometry analysis using VisionWorksLS or using the Odyssey CLx software.
Immunofluorescence
To visualize DDR1 in FAs, cells were plated in serum free medium on slides coated with collagen I (20 µg/ml) or fibronectin (10 µg/ml, Sigma). After 1 h the cells were fixed, in 4% paraformaldehyde in PBS for 15 min and then incubated with 5% BSA containing 0.3% Triton X-100 in PBS. After 2 h, cells were incubated with anti-DDR1 and anti-12G10 antibodies, anti-DDR1 antibody and FITC-phalloidin, or anti-DDR1 and anti-paxillin antibodies followed by the appropriate Cy3-or Alexa488-conjugated secondary antibodies. Cells were then analyzed under an epifluorescence microscope (Nikon) or a Nikon TiE microscope equipped with a Total Internal Reflection Fluorescence (TIRF) illuminator and 100x/1.49 objective.
Recombinant Protein Expression and Purification
DDR1b cytoplasmic domains was previously described (
pET30a-Talin-HIS cDNA was transformed in competent ArcticExpress (DE3) E. Coli. For recombinant protein expression bacterial cells were grown at 30°C then induced with 1 mM isopropyl β-d-thiogalactoside (IPTG) (Sigma) 10°C for 20 h, pelleted, lysed with lysis buffer (Hepes 50 mM pH 6.8, NaCl 300mM, glycerol 10%, Tween 0.2%, DTT 0.5 mM) supplemented with lysonase (Novagen) and bacterial protease inhibitors (Sigma), clarified by centrifugation and then purified on a TALON metal affinity resin (Clontech) for the HIS-tagged proteins following manufacturer’s instructions To remove imidazole used for elution, proteins were applied on a Zeba Spin desalting columns then proteins were aliquoted and stored at −80°C.
DC1 and DC1-GVMGFP proteins were expressed in E. coli BL21 (Novagen), and purification was carried out by affinity chromatography on a HisTrap HP column (GE Healthcare) and subsequent dialysis against 20 mM acetic acid (regenerated cellulose, MWCO = 12–14 kDa). Protein purity was assessed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by Coomassie blue staining. Protein concentrations were measured using the BCA protein assay (Pierce). Samples were stored at −80°C.
Circular Dichroism Spectroscopy
Circular dichroism (CD) spectra were obtained on protein samples in phosphate buffered saline (PBS) using a Jasco J720 spectropolarimeter in a thermostatically-controlled cuvette (0.5 mm path length). Data were collected over 250 to 190 nm wavelengths (integration = 1 s at 0.2 nm intervals; bandwidth = 1 nm). Ten scans were collected for each sample, and the buffer contribution was subtracted. The ellipticity at 220 nm was monitored from 25 to 45°C with an average temperature slope of 10°C/h to assess thermal transitions.
ELISA
ELISA assays were performed as previously described (Olaru et al., 2014). Briefly, 96 well plates (Nunc, maxisorp) were coated with DDR1a or DDR1b cytoplasmic tails in 50 mM sodium bicarbonate buffer pH 9.5 overnight at 4°C at the indicated concentrations, blocked with 0.5% bovine serum albumin (BSA) protease and IgG-free (Sigma, cat. no A3059) in 50 mM Tris, pH 7.5, and 150 mM NaCl and sequentially incubated with anti-DDR1 (Santa Cruz) or biotinylated anti-HIS, followed by HRP-conjugated anti-rabbit or HRP-conjugated avidin (Life Technologies). Finally HRP substrate (Bio-Rad, cat no 172–1,064) was added to the wells and the absorbance was measured at 650 nm.
Solid Phase Binding Assay
For DDR1 binding assays purified recombinant talin head domain was coated on 96 well plates (Nunc, maxisorp) and plates were blocked as described above. DDR1 cytoplasmic constructs were added at increasing concentrations in 50 mM Tris, pH 7.5, 150 mM NaCl, 0.1% BSA, 2 mM DTT and 0.1% Tween 20 and plates were sealed and incubated overnight at 4°C. The plates were then washed with 50 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Tween and bound DDR1 was detected with anti-DDR1 antibody (Santa-Cruz) followed by HRP-conjugated anti-Rabbit secondary. As control for nonspecific binding, BSA-coated wells and THD FERM coated wells were incubated with anti-DDR1 antibody.
Streptavidin Pull-Down
Serum starved HEK cells expressing DDR1a-turbo, DDR1b-turbo or the biotin ligase turbo alone were plated on collagen I (30 µg/ml in 20 mM acetic acid) for 1–3 h in the presence of biotin (50 µM). Cells were washed with PBS then lysed in 50 mM Tris, pH 7.5, 150 mM NaCl, 1% IGEPAL, 0.4% SDS, 1 mM EGTA supplemented with protease and phosphatase inhibitors then biotinylated proteins were isolated using streptavidin-agarose (Thermo Scientific) following the manufacturer instructions. Proteins were eluted by denaturation in sample buffer at 95°C for 5 min then analyzed by western blot analysis. Input lysates shown on the figure represents 2–5% of the lysate used for the streptavidin pull down.
G-Lisa Activation Assay
Rac1-GTP levels were measured using the colorimetric G-LISA kit (Cytoskeleton #BK128) following the manufacturer’s instructions. Briefly, 24 h serum starved cells were trypsinized and either kept in suspension or plated on collagen I (30 µg/ml) at 37°C. After 30 min, they were washed with cold PBS then lysed using G-Lisa lysis buffer and equal amounts of proteins were added to plates coated with a Rac-GTP-binding protein. Bound active Rac, was detected with a Rac-specific antibody followed by an HRP-conjugated secondary antibody. The activated Rac1-GTP values were normalized for total Rac1 levels that were assessed by Western blot analysis.
In Vivo Lung Colonization
The in vivo experiments were approved by the Vanderbilt’s Institutional Animal Care and Use Committee and performed according to institutional animal care guidelines. Mice were housed in an AALAC-accredited animal facility following NIH guidelines. HEK-Vector-GFP, HEK-DDR1a-GFP, or HEK-DDR1b-GFP were injected via the tail vein into athymic nude male mice, 12–13 weeks old (n = 10 for HEK-Vector and HEK-DDR1b and 12 for HEK-DDR1a, 2 × 105 cell/animal in 200 µl). Two weeks after the injection, the mice were sacrificed, the lungs were removed and the numbers of GFP positive colonies within the lung parenchyma were evaluated by placing the lungs under an epifluorescence microscope and counting all the GFP-positive tumors in the lung. 2–3 images/animal were taken to document presence or absence of tumors in the lung.
Macromolecular Modelling of DDR1b-Talin Complex
Currently, there are no reported structures of DDR1b juxtamembrane region deposited in Protein Data Bank (PDB), nor are there any structures which could serve as templates for homology modeling. Hence we devised a protocol that combines comparative modeling with de novo structure prediction using the Rosetta software for protein modeling. In order to produce a tentative model of DDR1b interaction with FERM domain, we have relied on a structure of galline talin F3 domain in complex with a chimeric murine β3 integrin-PIP kinase peptide (PDB ID: 2h7e (Wegener et al., 2007)). As the integrin W739 residue is highly evolutionarily conserved and presumably equivalent to residue W534 of DDR1b, we have threaded the sequence of DDR1b linker (A505-Q541 encompassing an NPxY motif, Figure 3A) onto the integrin structure, enforcing the same initial conformation. The resultant starting structure of the DDR1b peptide in complex with talin has then been subject to FlexPepDock ab-initio, a Rosetta-based protocol for simultaneous folding, docking and refinement of peptides onto their protein interaction partners (Raveh et al., 2011). Docking and refinement of DDR1 has been performed under three regimes: 1) relaxation and repacking, 2) fully flexible docking, relaxation and repacking and 3) analogous to (ii), but with enforced anchoring between W359 in talin and W534 in DDR1b. For each regime we have conducted 200,000 independent energy minimization trajectories. The resultant models were analyzed based on the interface energy score dG_separate (Lewis and Kuhlman, 2011), that is a difference in computed energy of a complex and the energy of both chains pulled apart and minimized. The best scoring poses in all three regimes were very similar and captured the same conformation of DDR1b-talin interaction (Figure 3A).
Computational Mutagenesis Evaluation of Validity of Proposed Pose
In order to evaluate the robustness and estimate the energetics of interaction, we have conducted an extensive computational mutagenesis experiment. For each amino acid position indicated by Rosetta as contributing significantly to DDR1b/talin binding, we mutated it to each of the 19 other genetically encoded amino acids. The mutated starting structures have then been relaxed, rendering 50 models for each residue type. Each of the models has been subject to binding energy calculations by means of Rosetta InterfaceAnalyzer (Lewis and Kuhlman, 2011) and the most favorable pose in terms of computed binding energy across interface (dG_cross) has been used for subsequent computation. The binding energy of a mutated pose has been subtracted from the binding energy of the “native” pose, allowing us to roughly quantify the effects of mutations. Full results of the computational mutagenesis can be found in Supplementary Figure S4.
Image Analysis
Images were captured with a Nikon epifluorescence microscope using a 40x or a 60x oil immersion objective using the appropriate fluorescence channels or Nikon TiE microscope equipped with a Total Internal Reflection Fluorescence (TIRF) illuminator and 100x/1.49 objective. The individual images were converted to tiff files and then Adobe Photoshop was used to produce the final figures. Mean fluorescence intensity was quantified using ImageJ (National Institutes of Health, Bethesda) and the JaCoP plugin Manders’ overlap coefficient (
Statistical Analysis
Data are shown as mean ± SEM. Statistical analysis was performed using GraphPad Prism software (9 version). To evaluate the statistical significance of the differences between groups we used unpaired two tailed t-test for two groups or One-way ANOVA (assuming Gaussian distribution) followed by Tukey’s test for pairwise comparisons within multiple groups A p ≤ 0.05 was considered to be statistically significant.
Statements
Data availability statement
The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.
Ethics statement
The in vivo experiments were approved by the Vanderbilt’s Institutional Animal Care and Use Committee and performed according to institutional animal care guidelines.
Author contributions
CB, conceptualization, supervision, data collection and analysis, original draft, review and editing, funding acquisition. GB, data collection and analysis, original draft. XZ, data collection. MB, resources. MZ, investigation, review and editing. JM, investigation, review and editing. MS, investigation, review and editing. RH, review and editing. LL, resources. JG, resources. MH, resources. JR, resources. KB, resources. BL, resources. MT, investigation. MM, resources. RB, resources, methodology. RZ, resources, review and editing. AP, conceptualization, supervision, visualization, data collection and analysis, original draft, review and editing, funding acquisition.
Funding
This work was supported in part by National Institutes of Health grants P30-DK114809 (AP, M-ZZ, RH, RZ), R01-DK119212 (AP, CB); R01 DK069921 (RZ); by Department of Veterans Affairs Merit Reviews 1I01BX002025 (AP), 1I01BX002196 (RZ); and the Deutsche Forschungsgemeinschaft (SFB914, project A05 to RB). AP is the recipient of a Department of Veterans Affairs Senior Research Career Scientist Award.
Acknowledgments
We wish to thank Catherine E. Alford for her assistance with the FACS analysis and Bing Yao for his assistance with in vivo lung colonization studies.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2022.836797/full#supplementary-material
References
1
AbairT. D.SundaramoorthyM.ChenD.HeinoJ.IvaskaJ.HudsonB. G.et al (2008). Cross-talk between Integrins Alpha1beta1 and Alpha2beta1 in Renal Epithelial Cells. Exp. Cel Res.314, 3593–3604.
2
AlvesF.VogelW.MossieK.MillauerB.HöflerH.UllrichA. (1995). Distinct Structural Characteristics of Discoidin I Subfamily Receptor Tyrosine Kinases and Complementary Expression in Human Cancer. Oncogene10, 609–618.
3
AmbrogioC.Gómez-LópezG.FalconeM.VidalA.NadalE.CrosettoN.et al (2016). Combined Inhibition of DDR1 and Notch Signaling Is a Therapeutic Strategy for KRAS-Driven Lung Adenocarcinoma. Nat. Med.22, 270–277. 10.1038/nm.4041
4
AnB.AbbonanteV.XuH.GavriilidouD.YoshizumiA.BihanD.et al (2016). Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor Functions as a Receptor Inhibitor. J. Biol. Chem.291, 4343–4355. 10.1074/jbc.m115.674507
5
AustenK.RingerP.MehlichA.Chrostek-GrashoffA.KlugerC.KlingnerC.et al (2015). Extracellular Rigidity Sensing by Talin Isoform-specific Mechanical Linkages. Nat. Cel Biol.17, 1597–1606. 10.1038/ncb3268
6
BayerS. V.GritherW. R.BrenotA.HwangP. Y.BarcusC. E.ErnstM.et al (2019). DDR2 Controls Breast Tumor Stiffness and Metastasis by Regulating Integrin Mediated Mechanotransduction in CAFs. eLife8, e45508. 10.7554/elife.45508
7
BolteS.CordelièresF. P. (2006). A Guided Tour into Subcellular Colocalization Analysis in Light Microscopy. J. Microsc.224, 213–232. 10.1111/j.1365-2818.2006.01706.x
8
BorzaC. M.BolasG.BockF.ZhangX.AkaboguF. C.ZhangM. Z.et al (2021). DDR1 Contributes to Kidney Inflammation and Fibrosis by Promoting the Phosphorylation of BCR and STAT3. JCI Insight1, e150887. 10.1172/jci.insight.150887
9
BorzaC. M.ChenX.MathewS.MontS.SandersC. R.ZentR.et al (2010). Integrin α1β1 Promotes Caveolin-1 Dephosphorylation by Activating T Cell Protein-Tyrosine Phosphatase. J. Biol. Chem.285, 40114–40124. 10.1074/jbc.m110.156729
10
BorzaC. M.PozziA.BorzaD.-B.PedchenkoV.HellmarkT.HudsonB. G.et al (2006). Integrin α3β1, a Novel Receptor for α3(IV) Noncollagenous Domain and a Trans-dominant Inhibitor for Integrin αvβ3. J. Biol. Chem.281, 20932–20939. 10.1074/jbc.m601147200
11
BorzaC. M.PozziA. (2014). Discoidin Domain Receptors in Disease. Matrix Biol.34, 185–192. 10.1016/j.matbio.2013.12.002
12
BorzaC. M.SuY.TranT.-L.YuL.SteynsN.TempleK. J.et al (2017). Discoidin Domain Receptor 1 Kinase Activity Is Required for Regulating Collagen IV Synthesis. Matrix Biol.57-58, 258–271. 10.1016/j.matbio.2016.11.009
13
BourgotI.PrimacI.LouisT.NoëlA.MaquoiE. (2020). Reciprocal Interplay between Fibrillar Collagens and Collagen-Binding Integrins: Implications in Cancer Progression and Metastasis. Front. Oncol.10, 1488. 10.3389/fonc.2020.01488
14
CalderwoodD. A.CampbellI. D.CritchleyD. R. (2013). Talins and Kindlins: Partners in Integrin-Mediated Adhesion. Nat. Rev. Mol. Cel Biol.14, 503–517. 10.1038/nrm3624
15
CalderwoodD. A.YanB.de PeredaJ. M.AlvarezB. G.FujiokaY.LiddingtonR. C.et al (2002). The Phosphotyrosine Binding-like Domain of Talin Activates Integrins. J. Biol. Chem.277, 21749–21758. 10.1074/jbc.m111996200
16
CarafoliF.MayerM. C.ShiraishiK.PechevaM. A.ChanL. Y.NanR.et al (2012). Structure of the Discoidin Domain Receptor 1 Extracellular Region Bound to an Inhibitory Fab Fragment Reveals Features Important for Signaling. Structure20, 688–697. 10.1016/j.str.2012.02.011
17
CaseL. B.WatermanC. M. (2015). Integration of Actin Dynamics and Cell Adhesion by a Three-Dimensional, Mechanosensitive Molecular Clutch. Nat. Cel Biol.17, 955–963. 10.1038/ncb3191
18
ChenY. L.TsaiW. H.KoY. C.LaiT. Y.ChengA. J.ShiahS. G.et al (2020). Discoidin Domain Receptor-1 (DDR1) Is Involved in Angiolymphatic Invasion in Oral Cancer. Cancers (Basel)12, 841. 10.3390/cancers12040841
19
ChiusaM.HuW.LiaoH.-J.SuY.BorzaC. M.de CaesteckerM. P.et al (2019). The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus. Jasn30, 1605–1624. 10.1681/asn.2018111160
20
ChoY. J.CunnickJ. M.YiS.-J.KaartinenV.GroffenJ.HeisterkampN. (2007). Abr and Bcr, Two Homologous Rac GTPase-Activating Proteins, Control Multiple Cellular Functions of Murine Macrophages. Mol. Cel Biol.27, 899–911. 10.1128/mcb.00756-06
21
CoelhoN. M.AroraP. D.van PuttenS.BooS.PetrovicP.LinA. X.et al (2017). Discoidin Domain Receptor 1 Mediates Myosin-dependent Collagen Contraction. Cel Rep.18, 1774–1790. 10.1016/j.celrep.2017.01.061
22
Cosgriff-HernandezE.HahnM. S.RussellB.WilemsT.Munoz-PintoD.BrowningM. B.et al (2010). Bioactive Hydrogels Based on Designer Collagens. Acta Biomater.6, 3969–3977. 10.1016/j.actbio.2010.05.002
23
CritchleyD. R. (2009). Biochemical and Structural Properties of the Integrin-Associated Cytoskeletal Protein Talin. Annu. Rev. Biophys.38, 235–254. 10.1146/annurev.biophys.050708.133744
24
CunnickJ. M.SchmidhuberS.ChenG.YuM.YiS.-J.ChoY. J.et al (2009). Bcr and Abr Cooperate in Negatively Regulating Acute Inflammatory Responses. Mol. Cel Biol.29, 5742–5750. 10.1128/mcb.00357-09
25
CuratC. A.EckM.DervillezX.VogelW. F. (2001). Mapping of Epitopes in Discoidin Domain Receptor 1 Critical for Collagen Binding. J. Biol. Chem.276, 45952–45958. 10.1074/jbc.m104360200
26
DengJ.KangY.ChengC. C.LiX.DaiB.KatzM. H.et al (2021). DDR1-induced Neutrophil Extracellular Traps Drive Pancreatic Cancer Metastasis. JCI Insight6, e146133. 10.1172/jci.insight.146133
27
HaakeS. M.LiJ.BaiY.KinoseF.FangB.WelshE. A.et al (2016). Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics. Clin. Cancer Res.22 (22), 5605–5616. 10.1158/1078-0432.ccr-15-1673
28
Hidalgo-CarcedoC.HooperS.ChaudhryS. I.WilliamsonP.HarringtonK.LeitingerB.et al (2011). Collective Cell Migration Requires Suppression of Actomyosin at Cell-Cell Contacts Mediated by DDR1 and the Cell Polarity Regulators Par3 and Par6. Nat. Cel Biol.13, 49–59. 10.1038/ncb2133
29
HuangY.AroraP.McCullochC. A.VogelW. F. (2009). The Collagen Receptor DDR1 Regulates Cell Spreading and Motility by Associating with Myosin IIA. J. Cel Sci.122, 1637–1646. 10.1242/jcs.046219
30
ItohY. (2018). Discoidin Domain Receptors: Microenvironment Sensors that Promote Cellular Migration and Invasion. Cell Adh Migr12, 378–385. 10.1080/19336918.2018.1460011
31
JeffriesD. E.BorzaC. M.BlobaumA. L.PozziA.LindsleyC. W. (2020). Discovery of VU6015929: A Selective Discoidin Domain Receptor 1/2 (DDR1/2) Inhibitor to Explore the Role of DDR1 in Antifibrotic Therapy. ACS Med. Chem. Lett.11, 29–33. 10.1021/acsmedchemlett.9b00382
32
JeitanyM.LeroyC.TostiP.LafitteM.Le GuetJ.SimonV.et al (2018). Inhibition of DDR1-BCR Signalling by Nilotinib as a New Therapeutic Strategy for Metastatic Colorectal Cancer. EMBO Mol. Med.10, e7918. 10.15252/emmm.201707918
33
JuinA.Di MartinoJ.LeitingerB.HenrietE.GaryA.-S.PaysanL.et al (2014). Discoidin Domain Receptor 1 Controls Linear Invadosome Formation via a Cdc42-Tuba Pathway. J. Cel Biol.207, 517–533. 10.1083/jcb.201404079
34
KechagiaJ. Z.IvaskaJ.Roca-CusachsP. (2019). Integrins as Biomechanical Sensors of the Microenvironment. Nat. Rev. Mol. Cel Biol.20, 457–473. 10.1038/s41580-019-0134-2
35
KimC.YeF.HuX.GinsbergM. H. (2012). Talin Activates Integrins by Altering the Topology of the β Transmembrane Domain. J. Cel Biol.197, 605–611. 10.1083/jcb.201112141
36
KweonS.-M.ChoY. J.MinooP.GroffenJ.HeisterkampN. (2008). Activity of the Bcr GTPase-Activating Domain Is Regulated through Direct Protein/protein Interaction with the Rho Guanine Nucleotide Dissociation Inhibitor. J. Biol. Chem.283, 3023–3030. 10.1074/jbc.m705513200
37
LeeJ.-H.PoudelB.KiH.-H.NepaliS.LeeY.-M.ShinJ.-S.et al (2018). Complement C1q Stimulates the Progression of Hepatocellular Tumor through the Activation of Discoidin Domain Receptor 1. Sci. Rep.8, 4908. 10.1038/s41598-018-23240-6
38
LeeY.-C.KurtovaA. V.XiaoJ.NikolosF.HayashiK.TramelZ.et al (2019). Collagen-rich Airway Smooth Muscle Cells Are a Metastatic Niche for Tumor Colonization in the Lung. Nat. Commun.10, 2131. 10.1038/s41467-019-09878-4
39
LeitingerB. (2003). Molecular Analysis of Collagen Binding by the Human Discoidin Domain Receptors, DDR1 and DDR2. J. Biol. Chem.278, 16761–16769. 10.1074/jbc.m301370200
40
LeitingerB. (2011). Transmembrane Collagen Receptors. Annu. Rev. Cel Dev. Biol.27, 265–290. 10.1146/annurev-cellbio-092910-154013
41
LemeerS.BluwsteinA.WuZ.LeberfingerJ.MüllerK.KramerK.et al (2012). Phosphotyrosine Mediated Protein Interactions of the Discoidin Domain Receptor 1. J. Proteomics75, 3465–3477. 10.1016/j.jprot.2011.10.007
42
LewisS. M.KuhlmanB. A. (2011). Anchored Design of Protein-Protein Interfaces. PLoS ONE6, e20872. 10.1371/journal.pone.0020872
43
LinY.JinH.WuX.JianZ.ZouX.HuangJ.et al (2020). The Cross-Talk between DDR1 and STAT3 Promotes the Development of Hepatocellular Carcinoma. Aging12, 14391–14405. 10.18632/aging.103482
44
Macias-PerezI. M.ZentR.CarmosinoM.BreyerM. D.BreyerR. M.PozziA. (2008). Mouse EP3 α, β, and γ Receptor Variants Reduce Tumor Cell Proliferation and Tumorigenesis In Vivo. J. Biol. Chem.283, 12538–12545. 10.1074/jbc.m800105200
45
MoserM.LegateK. R.ZentR.FässlerR. (2009). The Tail of Integrins, Talin, and Kindlins. Science324, 895–899. 10.1126/science.1163865
46
MouldA. P.GarrattA. N.AskariJ. A.AkiyamaS. K.HumphriesM. J. (1995). Identification of a Novel Anti-integrin Monoclonal Antibody that Recognises a Ligand-Induced Binding Site Epitope on the β1 Subunit. FEBS Lett.363, 118–122. 10.1016/0014-5793(95)00301-o
47
OlaruF.LuoW.SuleimanH.St. JohnP. L.GeL.MezoA. R.et al (2014). Neonatal Fc Receptor Promotes Immune Complex-Mediated Glomerular Disease. Jasn25, 918–925. 10.1681/asn.2013050498
48
ParkA. R.OhD.LimS. H.ChoiJ.MoonJ.YuD. Y.et al (2012). Regulation of Dendritic Arborization by BCR Rac1 GTPase-Activating Protein, a Substrate of PTPRT. J. Cel Sci.125, 4518–4531. 10.1242/jcs.105502
49
PraekeltU.KoppP. M.RehmK.LinderS.BateN.PatelB.et al (2012). New Isoform-specific Monoclonal Antibodies Reveal Different Sub-cellular Localisations for Talin1 and Talin2. Eur. J. Cel Biol.91, 180–191. 10.1016/j.ejcb.2011.12.003
50
RamR.LorenteG.NikolichK.UrferR.FoehrE.NagavarapuU. (2006). Discoidin Domain Receptor-1a (DDR1a) Promotes Glioma Cell Invasion and Adhesion in Association with Matrix Metalloproteinase-2. J. Neurooncol.76, 239–248. 10.1007/s11060-005-6874-1
51
RavehB.LondonN.ZimmermanL.Schueler-FurmanO. (2011). Rosetta FlexPepDock Ab-Initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their Receptors. PLoS ONE6, e18934. 10.1371/journal.pone.0018934
52
RikovaK.GuoA.ZengQ.PossematoA.YuJ.HaackH.et al (2007). Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer. Cell.131, 1190–1203. 10.1016/j.cell.2007.11.025
53
RobertsM. E.MagowanL.HallI. P.JohnsonS. R. (2011). Discoidin Domain Receptor 1 Regulates Bronchial Epithelial Repair and Matrix Metalloproteinase Production. Eur. Respir. J.37, 1482–1493. 10.1183/09031936.00039710
54
RognoniE.RuppertR.FässlerR. (2016). The Kindlin Family: Functions, Signaling Properties and Implications for Human Disease. J. Cel Sci.129, 17–27. 10.1242/jcs.161190
55
RomayorI.MárquezJ.BenedictoA.HerreroA.ArtetaB.OlasoE. (2021). Tumor DDR1 Deficiency Reduces Liver Metastasis by colon Carcinoma and Impairs Stromal Reaction. Am. J. Physiology-Gastrointestinal Liver Physiol.320, G1002–G1013. 10.1152/ajpgi.00078.2021
56
ScherpereelA.GentinaT.GrigoriuB.SénéchalS.JaninA.TsicopoulosA.et al (2003). Overexpression of Endocan Induces Tumor Formation. Cancer Res.63, 6084–6089.
57
SeoN.RussellB. H.RiveraJ. J.LiangX.XuX.Afshar-KharghanV.et al (2010). An Engineered α1 Integrin-Binding Collagenous Sequence. J. Biol. Chem.285, 31046–31054. 10.1074/jbc.m110.151357
58
ShintaniY.FukumotoY.ChaikaN.SvobodaR.WheelockM. J.JohnsonK. R. (2008). Collagen I-Mediated Up-Regulation of N-Cadherin Requires Cooperative Signals from Integrins and Discoidin Domain Receptor 1. J. Cel Biol.180, 1277–1289. 10.1083/jcb.200708137
59
ShrivastavaA.RadziejewskiC.CampbellE.KovacL.McGlynnM.RyanT. E.et al (1997). An Orphan Receptor Tyrosine Kinase Family Whose Members Serve as Nonintegrin Collagen Receptors. Mol. Cel1, 25–34. 10.1016/s1097-2765(00)80004-0
60
StaudingerL. A.SpanoS. J.LeeW.CoelhoN.RajshankarD.BendeckM. P.et al (2013). Interactions between the Discoidin Domain Receptor 1 and β1 Integrin Regulate Attachment to Collagen. Biol. open2, 1148–1159. 10.1242/bio.20135090
61
SunX.WuB.ChiangH.-C.DengH.ZhangX.XiongW.et al (2021). Tumour DDR1 Promotes Collagen Fibre Alignment to Instigate Immune Exclusion. Nature599, 673–678. 10.1038/s41586-021-04057-2
62
SunZ.CostellM.FässlerR. (2019). Integrin Activation by Talin, Kindlin and Mechanical Forces. Nat. Cel Biol.21, 25–31. 10.1038/s41556-018-0234-9
63
TheodosiouM.WidmaierM.BottcherR. T.RognoniE.VeeldersM.BharadwajM.et al (2016). Kindlin-2 Cooperates with Talin to Activate Integrins and Induces Cell Spreading by Directly Binding Paxillin. eLife5, e10130. 10.7554/elife.10130
64
VarnaiteR.MacNeillS. A. (2016). Meet the Neighbors: Mapping Local Protein Interactomes by Proximity-dependent Labeling with BioID. Proteomics16, 2503–2518. 10.1002/pmic.201600123
65
VogelW.BrakebuschC.FässlerR.AlvesF.RuggieroF.PawsonT. (2000). Discoidin Domain Receptor 1 Is Activated Independently of β1 Integrin. J. Biol. Chem.275, 5779–5784. 10.1074/jbc.275.8.5779
66
VogelW.GishG. D.AlvesF.PawsonT. (1997). The Discoidin Domain Receptor Tyrosine Kinases Are Activated by Collagen. Mol. Cel1, 13–23. 10.1016/s1097-2765(00)80003-9
67
VonckenJ. W.SchaickH. v.KaartinenV.DeemerK.CoatesT.LandingB.et al (1995). Increased Neutrophil Respiratory Burst in Bcr-Null Mutants. Cell.80, 719–728. 10.1016/0092-8674(95)90350-x
68
WangC.-Z.SuH.-W.HsuY.-C.ShenM.-R.TangM.-J. (2006). A Discoidin Domain Receptor 1/SHP-2 Signaling Complex Inhibits α2β1-Integrin-mediated Signal Transducers and Activators of Transcription 1/3 Activation and Cell Migration. MBoC17, 2839–2852. 10.1091/mbc.e05-11-1068
69
WasinskiB.SohailA.BonfilR. D.KimS.SaligananA.PolinL.et al (2020). Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts. Sci. Rep.10, 2309. 10.1038/s41598-020-59028-w
70
WegenerK. L.PartridgeA. W.HanJ.PickfordA. R.LiddingtonR. C.GinsbergM. H.et al (2007). Structural Basis of Integrin Activation by Talin. Cell.128, 171–182. 10.1016/j.cell.2006.10.048
71
XuH.BihanD.ChangF.HuangP. H.FarndaleR. W.LeitingerB. (2012). Discoidin Domain Receptors Promote Alpha1beta1- and Alpha2beta1-Integrin Mediated Cell Adhesion to Collagen by Enhancing Integrin Activation. PLoS One7, e52209. 10.1371/journal.pone.0052209
72
XuH.RaynalN.StathopoulosS.MyllyharjuJ.FarndaleR. W.LeitingerB. (2011). Collagen Binding Specificity of the Discoidin Domain Receptors: Binding Sites on Collagens II and III and Molecular Determinants for Collagen IV Recognition by DDR1. Matrix Biol.30, 16–26. 10.1016/j.matbio.2010.10.004
73
YangS. H.BaekH. A.LeeH. J.ParkH. S.JangK. Y.KangM. J.et al (2010). Discoidin Domain Receptor 1 Is Associated with Poor Prognosis of Non-small Cell Lung Carcinomas. Oncol. Rep.24, 311–319. 10.3892/or_00000861
74
YehY.-C.WangC.-Z.TangM.-J. (2009). Discoidin Domain Receptor 1 Activation Suppresses α2β1integrin-dependent Cell Spreading through Inhibition of Cdc42 Activity. J. Cel. Physiol.218, 146–156. 10.1002/jcp.21578
75
YeungD. A.ShankerN.SohailA.WeissB. A.WangC.WellmerlingJ.et al (2019). Clustering, Spatial Distribution, and Phosphorylation of Discoidin Domain Receptors 1 and 2 in Response to Soluble Collagen I. J. Mol. Biol.431, 368–390. 10.1016/j.jmb.2018.11.015
76
ZhuL.PlowE. F.QinJ. (2021). Initiation of Focal Adhesion Assembly by Talin and Kindlin: A Dynamic View. Protein Sci.30, 531–542. 10.1002/pro.4014
Summary
Keywords
receptor tyrosine kinase, integrins, extracellular matrix, migration, receptor activation, Rac1
Citation
Borza CM, Bolas G, Zhang X, Browning Monroe MB, Zhang M-Z, Meiler J, Skwark MJ, Harris RC, Lapierre LA, Goldenring JR, Hook M, Rivera J, Brown KL, Leitinger B, Tyska MJ, Moser M, Böttcher RT, Zent R and Pozzi A (2022) The Collagen Receptor Discoidin Domain Receptor 1b Enhances Integrin β1-Mediated Cell Migration by Interacting With Talin and Promoting Rac1 Activation. Front. Cell Dev. Biol. 10:836797. doi: 10.3389/fcell.2022.836797
Received
15 December 2021
Accepted
04 February 2022
Published
03 March 2022
Volume
10 - 2022
Edited by
Elvira Olaso, University of the Basque Country, Spain
Reviewed by
Gunjan Agarwal, The Ohio State University, United States
Audrey Sirvent, UMR5237 Centre de Recherche en Biologie cellulaire de Montpellier (CRBM), France
Updates

Check for updates
Copyright
© 2022 Borza, Bolas, Zhang, Browning Monroe, Zhang, Meiler, Skwark, Harris, Lapierre, Goldenring, Hook, Rivera, Brown, Leitinger, Tyska, Moser, Böttcher, Zent and Pozzi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Corina M. Borza, corina.borza@vumc.org; Ambra Pozzi, ambra.pozzi@vumc.org
† These authors share first authorship
‡ Present Address: Marcin J. Skwark, InstaDeep Ltd, London, United Kigdom Markus Moser, School of Medicine, Institute of Experimental Hematology, Technische Universität München, Munich, Germany
This article was submitted to Signaling, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.